Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (209)

Published on in Vol 6, No 9 (2017): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8631, first published .
Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Authors of this article:

Mina Amiri1, 2 Author Orcid Image ;   Fatemeh Nahidi1 Author Orcid Image ;   Davood Khalili3 Author Orcid Image ;   Razieh Bidhendi-Yarandi2, 4 Author Orcid Image ;   Fahimeh Ramezani Tehrani2 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. WALKER K, DECHERNEY A, SAUNDERS R. Menstrual Dysfunction in PCOS. Clinical Obstetrics & Gynecology 2021;64(1):119 View
  2. Sun R, Xu H, Ma R, Xu J, Liu Y, Mao D. Clinical and endocrine effects of pharmacological therapy in endometriosis: a systematic review and meta-analysis. Frontiers in Endocrinology 2026;17 View

Books/Policy Documents

  1. Cagnacci A, Biasioli A. Female and Male Contraception. View